JPWO2020252378A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020252378A5
JPWO2020252378A5 JP2021573843A JP2021573843A JPWO2020252378A5 JP WO2020252378 A5 JPWO2020252378 A5 JP WO2020252378A5 JP 2021573843 A JP2021573843 A JP 2021573843A JP 2021573843 A JP2021573843 A JP 2021573843A JP WO2020252378 A5 JPWO2020252378 A5 JP WO2020252378A5
Authority
JP
Japan
Prior art keywords
crispr
nucleic acid
target nucleic
related protein
nucleotides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021573843A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022538789A5 (https=
JP2022538789A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/037585 external-priority patent/WO2020252378A1/en
Publication of JP2022538789A publication Critical patent/JP2022538789A/ja
Publication of JPWO2020252378A5 publication Critical patent/JPWO2020252378A5/ja
Publication of JP2022538789A5 publication Critical patent/JP2022538789A5/ja
Pending legal-status Critical Current

Links

JP2021573843A 2019-06-14 2020-06-12 新規crispr dnaターゲティング酵素及びシステム Pending JP2022538789A (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US201962861582P 2019-06-14 2019-06-14
US62/861,582 2019-06-14
US201962872157P 2019-07-09 2019-07-09
US62/872,157 2019-07-09
US201962873602P 2019-07-12 2019-07-12
US201962873606P 2019-07-12 2019-07-12
US62/873,602 2019-07-12
US62/873,606 2019-07-12
PCT/US2020/037585 WO2020252378A1 (en) 2019-06-14 2020-06-12 Novel crispr dna targeting enzymes and systems

Publications (3)

Publication Number Publication Date
JP2022538789A JP2022538789A (ja) 2022-09-06
JPWO2020252378A5 true JPWO2020252378A5 (https=) 2023-06-19
JP2022538789A5 JP2022538789A5 (https=) 2023-06-19

Family

ID=73781310

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021573843A Pending JP2022538789A (ja) 2019-06-14 2020-06-12 新規crispr dnaターゲティング酵素及びシステム

Country Status (7)

Country Link
US (1) US20220315913A1 (https=)
EP (1) EP3983536A4 (https=)
JP (1) JP2022538789A (https=)
CN (1) CN114269912A (https=)
AU (1) AU2020291467A1 (https=)
CA (1) CA3142019A1 (https=)
WO (1) WO2020252378A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220282283A1 (en) * 2019-09-05 2022-09-08 Arbor Biotechnologies, Inc. Novel crispr dna targeting enzymes and systems
US20240093228A1 (en) * 2021-01-22 2024-03-21 Arbor Biotechnologies, Inc. Compositions comprising a nuclease and uses thereof
IL308806A (en) 2021-06-01 2024-01-01 Arbor Biotechnologies Inc Gene editing systems including nuclease crisper and their uses
WO2024173645A1 (en) 2023-02-15 2024-08-22 Arbor Biotechnologies, Inc. Gene editing method for inhibiting aberrant splicing in stathmin 2 (stmn2) transcript
WO2025171210A1 (en) 2024-02-09 2025-08-14 Arbor Biotechnologies, Inc. Compositions and methods for gene editing via homology-mediated end joining
WO2025201481A1 (en) * 2024-03-29 2025-10-02 Yoltech Therapeutics Co., Ltd Crispr-cas systems
WO2026015832A2 (en) 2024-07-12 2026-01-15 Arbor Biotechnologies, Inc. Reverse transcriptases and gene editing systems comprising such
WO2026015829A2 (en) 2024-07-12 2026-01-15 Arbor Biotechnologies, Inc. Small reverse transcriptases and gene editing systems comprising such

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9074199B1 (en) * 2013-11-19 2015-07-07 President And Fellows Of Harvard College Mutant Cas9 proteins
WO2017044776A1 (en) * 2015-09-10 2017-03-16 Texas Tech University System Single-guide rna (sgrna) with improved knockout efficiency
US10017760B2 (en) * 2016-06-24 2018-07-10 Inscripta, Inc. Methods for generating barcoded combinatorial libraries
WO2018125964A1 (en) * 2016-12-28 2018-07-05 Ionis Pharmaceuticals, Inc. Modified crispr rna and uses thereof
US9982279B1 (en) * 2017-06-23 2018-05-29 Inscripta, Inc. Nucleic acid-guided nucleases
US11713452B2 (en) * 2017-09-08 2023-08-01 University Of North Texas Health Science Center Engineered CAS9 variants
WO2019090175A1 (en) * 2017-11-02 2019-05-09 Arbor Biotechnologies, Inc. Novel crispr-associated transposon systems and components

Similar Documents

Publication Publication Date Title
O'Connell Molecular mechanisms of RNA targeting by Cas13-containing type VI CRISPR–Cas systems
JP2025161809A5 (https=)
US11840694B2 (en) Truncated CRISPR-Cas proteins for DNA targeting
JP2023088984A5 (https=)
FI3765615T3 (fi) Uusia DNA:han kohdentuvia CRISPR-entsyymejä ja järjestelmiä
WO2019232069A1 (en) Cell therapy
JP2025170240A5 (https=)
FI3802807T3 (fi) Rna-ohjattuja nukleaaseja ja niiden aktiivisia fragmentteja ja variantteja ja menetelmiä niiden käyttämiseksi
JP2023538964A (ja) 真核生物ゲノム工学のための合成小型crispr-cas(casmini)システム
EP3611258A1 (en) System and method for genome editing
JPWO2021050571A5 (https=)
JPWO2019236566A5 (https=)
JPWO2021030344A5 (https=)
EP4640697A1 (en) Complex and use thereof
JPWO2020252378A5 (https=)
WO2024131940A1 (zh) 融合物及其用途
JPWO2021050534A5 (https=)
Goshayeshi et al. CRISPR/dCas9‐mediated transposition with specificity and efficiency of site‐directed genomic insertions
JPWO2021102390A5 (https=)
JPWO2019236982A5 (https=)
JPWO2021007563A5 (https=)
JPWO2020181102A5 (https=)
JPWO2022256440A5 (https=)
US20240279687A1 (en) Peptide nucleic acids for spatiotemporal control of crispr-cas binding
CN110577969A (zh) CRISPR/Sa-SlugCas9基因编辑系统及其应用